Anzeige
Mehr »
Montag, 07.07.2025 - Börsentäglich über 12.000 News
EchoIQ von 3 Analysehäusern als "Best-in-Class" bewertet - Kurszielpotenzial von über 200?%
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40P16 | ISIN: SE0022419784 | Ticker-Symbol: 61L0
München
07.07.25 | 08:41
31,440 Euro
+1,81 % +0,560
1-Jahres-Chart
SECTRA AB Chart 1 Jahr
5-Tage-Chart
SECTRA AB 5-Tage-Chart
RealtimeGeldBriefZeit
31,44031,84016:24
PR Newswire
187 Leser
Artikel bewerten:
(1)

One of the largest multi-region healthcare systems in the US expands enterprise imaging cloud service from Sectra with pathology to leverage integrated diagnostics in cancer care

LINKÖPING, Sweden and SHELTON, Conn., July 7, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra's (STO: SECT B) module for digital pathology will be used by a US-based health system serving a multi-million strong patient community. This is an expansion of the healthcare provider's usage of Sectra's enterprise imaging solution as a cloud service, Sectra One Cloud. Together with the radiology and ophthalmology modules used today, the service now also equips pathologists with new tools and facilitates integrated diagnostics within cancer care.

"Unifying different types of medical imaging in one system enables closer collaboration across specialties. For example, having both radiology and pathology in the same system enables integrated diagnostics, which is key to improving patient care, especially within cancer. The decision to expand and include pathology demonstrates this healthcare provider's dedication to an integrated diagnostic approach," says Isaac Zaworski, President of Sectra Inc.

The pathology module allows pathologists to review and collaborate around cases digitally as well as benefit from AI tools. The digital workflow provides instant and, when needed, remote access to digital images of tissue samples instead of relying on physical glass slides reviewed in microscopes. With their pathologists and radiologists now sharing a unified system, it will pave the way for integrated diagnostics, which makes collaboration across different specialties more effective.

The healthcare provider is already using Sectra's radiology and ophthalmology modules and the contract for the expansion to digital pathology was signed in June 2025 following a successful pilot project. The contracted order value for the digital pathology expansion amounts to 8.9M USD for usage until 2033, if the full term of the contract is realized.

Read more about Sectra One Cloud>>

Sectra's enterprise imaging solution provides a unified strategy for all imaging needs in one single system thus both improving outcomes as well as lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise without acquiring a new backend. Visit Sectra's website to read more about Sectra and why it's top-ranked in 'Best in KLAS'.

About Sectra
Sectra contributes to a healthier and safer society by assisting health systems throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society's most sensitive information. The company, founded in 1978, is headquartered in Linköping, Sweden, with direct sales in 19 countries, and distribution partners worldwide. Sales in the 2024/2025 fiscal year totaled SEK 3,240 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit Sectra's website. For more information, visit Sectra's website.

For further information, please contact: Dr. Torbjörn Kronander, CEO and President Sectra AB, 46 (0) 705 23 52 27
Marie Ekström Trägårdh, Executive Vice President Sectra AB and President Sectra Imaging IT Solutions, 46 (0)708 23 56 10

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/sectra/r/one-of-the-largest-multi-region-healthcare-systems-in-the-us-expands-enterprise-imaging-cloud-servic,c4192076

The following files are available for download:

https://news.cision.com/sectra/i/sectra-s-digital-pathology-solution,c3444335

Sectra's digital pathology solution

Cision View original content:https://www.prnewswire.co.uk/news-releases/one-of-the-largest-multi-region-healthcare-systems-in-the-us-expands-enterprise-imaging-cloud-service-from-sectra-with-pathology-to-leverage-integrated-diagnostics-in-cancer-care-302498651.html

© 2025 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.